CD1d is involved in T cell-intestinal epithelial cell interactions by unknown
Btqef Detlnitlre Report 
CDld  Is Involved  in T  Cell-Intestinal  Epithelial 
Cell  Interactions 
By Asit Panja,* Richard S. Blumberg,   Steven P. Balk,$ 
and Lloyd Mayer* 
From the  *Division of Clinical Immunology,  Mount Sinai Medical Center, New York, 10029; 
the *Division of Gastroenterology, Brigham  and  Womens Hospital, Boston, Massachusetts 02115; 
and the SDivision of Hematology-Ontology,  Beth Israel Hospital, Boston, Massachusetts 02114 
Summary 
We assessed the role of the nonclassical class I molecule, CDld, in the interaction between intestinal 
epithelial cells and T cells. In a mixed lymphocyte reaction (MLR.) system where the stimulator 
cells were irradiated  normal intestinal cells,  the anti-CDld monoclonal antibody (mAb) 3Cll 
inhibited T  cell proliferation.  In contrast,  no inhibition  was seen when mAb 3Cll was added 
to conventional MLR cultures  (non T  cell stimulators).  Furthermore,  no inhibition  was seen 
when either airway epithelial cells were used as stimulator cells or lamina propria lymphocytes 
were used as responder cells. These latter two conditions along with a conventional MLR favor 
CD4 + T cell proliferation.  However, we have previously shown that normal intestinal epithelial 
cells  stimulate  CD8 +  T  cells  under  similar  culture  conditions.  Thus,  CDld  expressed  on 
intestinal epithelial cells may be an important ligand in CD8 + T cell-epithelial cell interactions. 
I 
mmune  responses at  mucosal sites  are,  by nature  of the 
environment,  subject to unique rules relating to recogni- 
tion and effector functions. Over the past several years, it has 
become clear that many of the dogmas set for peripheral im- 
mune responses have not held for mucosal immunity (1-3). 
Many of these may relate to how antigen is handled in the 
gastrointestinal (GI) tract. Proteins delivered via the stomach 
and small intestine are preprocessed by intestinal enzymes (4). 
The resultant  small peptides can be absorbed by the intes- 
tinal epithelium and could be delivered to the blood stream 
in a nonimmunogenic  form. However, several groups have 
recently demonstrated that intestinal epithelial cells (IEC) are 
capable of a more proactive role in Ag handling.  First,  as 
has been reported for a number of epithelia in vitro, IEC can 
express class II Ags and activate T  cells (5-9).  However, in 
contrast to the typical "non-professional"  APC, IEC, espe- 
dally in the small intestine, constitutively express class II mol- 
ecules in vivo (10, 11). This finding, along with their ability 
to take up large peptides and present them to primed T cells 
in vitro, suggest that IEC may play an important immuno- 
regulatory role in vivo. This regulatory role may relate to 
the general suppressed tone of the GI tract.  In fact, reports 
from several groups have demonstrated that IEC selectively 
activate suppressor T  cells that may be Ag nonspecific even 
when activated in Ag-specific interactions (5, 6). The mech- 
anism(s) resulting in the generation of these suppressor cells 
has not been clearly established. Our laboratory has demon- 
strated that the CD8 molecule itself plays a role in the sup- 
pressor T cell activation seen (12). However, the conventional 
ligand for CD8, class I, has no effect in this system. There- 
fore, additional molecules were sought that would potentially 
interact with CD8.  One such candidate is CDld,  a class I- 
like molecule recently reported to be expressed on murine 
and human IEC (13,  14). Whereas the functional relevance 
of CDld has not been defined, in this study we provide evi- 
dence that this molecule is an important component in epi- 
thelial  cell-T cell interactions. 
Materials  and Methods 
Cell Isolation and Culture.  PBMC were isolated from leukocyte 
concentrate packs as previously described (15). Further separation 
to T and non T cells was performed by rosetting  and density gra- 
dient separation on Ficoll-Hypaque (Pharmacia Fine Chemicals, Pis- 
cataway, NJ) (15). Lamina propria lymphocytes  (LPL) were iso- 
lated from surgically resected intestinal specimens using enzymatic 
techniques as previously described (16). Briefly, resected intestine 
was rinsed in cold calcium magnesium free (CMF)-HBSS (Gibco 
BILL, Gaithersburg,  MD),  containing  gentamicin  (50  /~g/ml) 
(Sigma Chemical Co., St. Louis, MO), peniciLlin/streptomycin (1% 
vol/vol (Gibco BILL), and amphotericin  B (1% vol/vol, Gibco BgL) 
and blotted free of mucus and debris on sterile gauze. The mucosa 
was stripped from the underlying submucosa by blunt dissection, 
cut into small 2-ram pieces, and incubated in dithiotheitol  (2 mM, 
Sigma Chemical Co.) for 5 rain. After this incubation, the mucosal 
pieces were washed three times in R.PMI 1640 (Gibco BILL) and 
incubated three to four times in CMF-HBSS containing EDTA (0.75 
mM, Sigma Chemical Co.). This suspension was rotated on a Ju- 
nior Orbital Shaker (Fisher, Springfield, NJ) at 40 ILPM for 45 
rain each at 37~  Liberated epithelial cells were removed by pas- 
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pieces were then incubated  overnight in RPMI 1640, 1% FCS (Flow 
Laboratories, Maclean, VA), collagenase (80 ng/ml, Boehringer 
Mannheim, Indianapolis, IN), DNase (0.1/~g/ml,  Sigma Chem- 
ical Co.), and soybean trypsin inhibitor (0.1 #g/ml, Sigma Chem- 
ical Co.). After incubation for 18 h, the liberated cells were col- 
lected by centrifugation and additional cells liberated by passage 
of tissue through a wire mesh. The resultant cell suspension was 
enriched for lymphocytes  by passage over a Percoll density gradient, 
as previously described (16), collecting cells at the interface of 
40--60% percoll. LPL were typically >95% HLe-1  § (T200) with 
2-5%  contaminating epithelial cells. 
IEC were isolated as previously described (5). Mucosal pieces 
(pre-EDTA) were incubated at 37~  in 50 ml RPMI containing 
Dispase (3 mg/ml, Boehringer Mannheim) for 30 min. The sus- 
pension was vortexed  every  5-10 min liberating  epithelial  ceUs. These 
cells could be freed from the mucosal pieces by passage through 
a Nytex filter. Epithelial cells were pelleted, washed three times 
in RPMI 1640, and irradiated 3,000 rad (cesium source) before use. 
Epithelial cells were free of contaminating B cells and mono- 
cytes/macrophages assessed  by the absence of CD19/20 and CD14 
staining. T cell contamination of about 2-5% was typically seen 
which could be reduced by subjecting epithelial  cells to Percoll den- 
sity gradient centrifugation (5). 
Isolation of airway epithelial cells (AEC) was performed from 
surgically resected specimens or bronchoalveolar lavage  specimens 
(17). Isolation from resections was performed using Dispase and 
agitation  as  described for  IEC.  AEC  were then  cultured  in 
DMEM/F12 (Gibco BILL)  in the absence of serum, but in the pres- 
ence of epidermal growth factor, insulin, transferrin, and hydrocor- 
tisone. After 5 d in culture, no viable monocytes were detectable 
and ciliary beating could still be seen on adherent epithelial cells. 
Plate-bound epithelium were irradiated 3,000 rad before coculture 
with T cells. 
Allogeneic Mixed Cell Cultures.  T cell-epithelial cell or non T 
cell cultures were incubated in RPMI 1640, 5% agammaglobuli- 
nemic serum, 1% penicillin/streptomycin, and 2 mM r-glutamine 
(Gibco BRL) (culture medium [CM]) for 5 d at 37~  in a 5% 
CO2 water-jacketed  incubator. During the last 18 h of the 5-d cul- 
ture, 1 #Ci [3H]thymidine  (aqueous methyl sp act, 1.9 mCi; ICN, 
Irvine, CA) was added and cells harvested  for counting as described 
(5). 
Allogeneic mixed cell cultures were established as follows: l0  s 
T cells or LPL were cultured in 100/~1 CM in triplicate cultures 
in the presence or absence of varying concentrations of irradiated 
(3,000 rad) stimulator cells (2  x  105, l0  s, 5  x  104 IEC, AEC, 
or non T cells). Background, unstimulated T cell proliferation was 
measured in cultures of T cells alone whereas a positive control 
of T cells stimulated with PHA (1/zg/ml, Gibco BRL) was in- 
cluded in each experiment. In no experiment did T cells fail to 
proliferate in response to PHA. 
Antibodies.  mAbs  3Cll and 1H1 are rat IgM anti-mouse CDld 
Abs that crossreact with human CDld as described (13, 14). 1H1 
appears to recognize an epitope or form of CDld distinct from 
that recognized by 3Cll. Abs were used as culture supernatant but 
adjusted to an Ab concentration of 10/~g/ml  stock solution. 
In most experiments, mAb were added directly to the culture 
wells for the 5 d of culture. Given the lack of inhibition by 1H1 
described in this paper, this mAb served as the isotype control for 
3Cll. Murine IgG1 anti-DNP served as the isotype  control for VG2. 
In some experiments,  epithelial  or T cells  were preincubated  with 
mAbs for 30 min at 4~  followed by washing with PBS, irradia- 
tion,  and coculture with T cells. 
Results 
Anti-CDld mAb 3Cll Inhibits Epithelial  Cell but Not Non 
T  Cell-driven  Allogeneic Mixed Cell Cultures.  Our previous 
studies (12) had shown that T cell-epithelial cell allogeneic 
mixed cell cultures could be inhibited by mAbs to CD8 but 
not its conventional ligand, class I MHC. These data sug- 
gested that CD8 was not only important in the process  of 
T  cell-IEC interaction, but also  that this molecule might 
be activated through an alternate ligand. The finding that 
CDld, a class I-like molecule, is expressed  on human IEC 
(14) made it a candidate for such an interaction. Anti-CDld 
mAb 3Cll was added at varying concentrations (1-5/~g/ml) 
to normal epithelial cell-T cell allogeneic mixed cell cultures. 
Inhibition (50-80%) ofT cell proliferation was seen in 8 of 
12 experiments (Fig. 1 A, representative of eight experiments). 
This inhibition was evident at varying epithelial cell concen- 
trations as well (Fig. 1 B). Anti-CDld mAb 1H1 which recog- 
nizes a different epitope or form of CDld on epithelial cells 
was unable to mediate inhibition in parallel cultures (Fig.  1 
C). Inhibition by 3Cll was mediated via binding to epithe- 
lial cells as pretreatment of epithelial cells, but not T  cells 
before allogeneic mixed cell culture was as effective in in- 
hibiting T cell proliferation as when Abs were left in culture 
throughout the allogeneic mixed cell culture incubatory period 
(data not shown). The inhibition by CDld mAb 3Cll is com- 
parable to the inhibitory effect of an anti-CD8 mAb in this 
system. The effect of anti-CD8 appears to be specific since 
it fails to inhibit the proliferation of PHA-stimulated T cells 
(Fig.  1 D). 
In contrast, neither 3Cll,  1H1,  nor anti-CD8 were able 
to inhibit conventional (T cell-non T cell) allogeneic MLRs 
(Fig. 2 A) suggesting that the inhibition seen in Fig.  1 was 
epithelial cell specific and not related to nonspecific  inhibi- 
tion of T cell activation. However, since the stimulated cell 
in epithelial cell-T cell allogeneic mixed cell cultures is the 
CD8 + T  cell,  the possibility exists  that anti-CDld mAbs 
selectively  inhibit CD8 §  T  cell activation. Therefore, we 
isolated CD8 + T cells from peripheral  blood and cocultured 
them with allogeneic non T cells. As seen in Fig. 2 B, 3Cll 
failed to inhibit CD8 § T cell proliferation induced by con- 
ventional stimulator cells, suggesting that the effect of anti- 
CDld might be specific for IEC-T cell allogeneic mixed cell 
cultures. 
mA b 3CI1 Fails to Inhibit Pe@heral Blood T-AEC Allogeneic 
Mixed Cell Cultures.  AEC may serve similar barrier func- 
tion to IEC, yet the Ag loaded in the lung is significantly 
less than that in the gut. This difference may underscore the 
functional differences that have been reported between these 
two cell types. Whereas both epithelia constitutively express 
class II molecules, only AEC stimulate CD4 § T cells (17). 
If, in fact, CDld is important in CD8 + T cell activation by 
IEC,  then mAb 3Cll should not inhibit peripheral blood 
T-AEC allogeneic mixed cell cultures. This indeed was the 
case. As seen in Fig. 3, mAb 3Cll failed to inhibit peripheral 
blood T-AEC cultures but was capable of inhibiting IEC stim- 
ulation of the same T cell preparation. Thus, consistent with 
the results seen with non T  cells, cultures where CD4 § T 
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Figure  1.  (.4) 10  s peripheral blood (PB) T cells were cocultured  with 
an equal number of irradiated (3,000 tad) freshly isolated IEC for 5 d in 
the presence or absence of varying concentrations of anti-CDld mAb 3Cll. 
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Figure  2.  (A) 3Cll fails to inhibit a conventional  MLR. Similar to the 
experimental  design of Fig.  1 B, varying  concentrations  of non T  cells 
were used to stimulate PB T cells in the presence (hatched bars) or absence 
(solid bars) of mAb 3Cll  (5/~g/ml).  No inhibition is seen.  This figure 
is representative of six experiments.  (B) CD8 + T  calls were isolated by 
sorting  and cocultured  with non T cells in a conventional  MLR culture 
in the presence or absence of anti-CDld mAb 3Cll. Similar to the findings 
in (.4),  no inhibition was seen. 
cell proliferation predominates are not inhibitable with the 
anti-CDld  mAb. 
mA b 3(]11 Does Not Inhibit LPL-Normal Epithelial Cell AI- 
Iogeneic Mixed Cell Cultures.  In  contrast  to  peripheral  T 
cell-IEC cultures where proliferation of CD8 + T cells pre- 
dominate, LPL-epithelial cell cultures result in the prolifera- 
tion of both CD4 and CD8 + T cells (Panja, A., A. Barone, 
and L. Mayer, manuscript submitted for publication). Addi- 
tion of mAb 3Cll to these allogeneic mixed cell cultures failed 
to produce any inhibition  (Fig.  4; representative  of six ex- 
periments). Thus the nature of the responder cell population 
is also critical in documenting the effects of 3Cll. In experi- 
is representative of eight experiments.  (B) As reported in (.4),  10  s PB T 
cells were cocultured  with either 2.5  x  104 or 5  x  104 irradiated (3,000 
rad) freshly isolated IEC for 5 d in the presence (hatched bars) or absence 
(solid bars) of anti-CDld mAb 3Cll (5/zg/ml). The isotype control mAb 
showed no inhibition (see Fig. 1 C). (C) Comparison of anti-CDld mAbs 
3Cll vs. 1H1. Whereas both stain intestinal epithelium in tissue section, 
only 3Cll was capable of mediating inhibition. (D) Ability of anti-CD8 
mAb to inhibit epidermal cell-driven T  cell proliferation.  T  cells were 
untreated or preincubated with the anti-CD8 mAb, OKT8, for 30 min 
at 4°C. After removal of excess mAb by washing, T cells were cocultured 
with either an equal number of irradiated (3,000 red) freshly isolated IEC 
for 5 d or PHA (1/zg/ml) for 3 d. Anti-CD8 inhibited IEC but not PHA 
stimulation of T  cells. 
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3Cll fails to inhibit an AEC-stimulated MLK.  10  s PB T 
cells were cocultured  with either an equal number of irradiated  (3,000 
rad) freshly isolated IEC (hatched bars) or AEC (solid bars) for 5 d in the 
presence or absence of varying concentrations  of anti-CDld mAbs 3Cll 
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Figure  4.  3Cll fails to inhibit an LPL-epithelial cell MLK. 10  s LP T 
cells were cocultured with varying numbers of irradiated (3,000 tad) freshly 
isolated IEC for 5 d in the presence (,)  or absence ([]) of varying con- 
centrations  of anti-CDld mAb 3Cll. This figure is representative  of six 
experiments. 
ments where epithelial  cells from one donor were used to 
stimulate either allogeneic peripheral blood T  cells or LPL 
from another donor, inhibition was seen only in peripheral 
blood cultures (data not shown). These data add further sup- 
port for the role of CDld in the activation of CD8 + periph- 
eral blood T  cells. 
Discussion 
CDld is a distinct member of the CD1 gene family which 
are nonpolymorphic MHC class I-like molecules. In contrast 
to CDla-c which are primarily expressed thymically and to 
a limited extent extrathymically,  CDld is primarily  an ex- 
trathymic molecule expressed on epithelial cells of a wide va- 
riety of tissues including the intestine (14, and Balk, S., and 
R. Blumberg, manuscript submitted for publication). Its func- 
tion in immune regulation has not been clearly determined 
although  there is some evidence that  it can be recognized 
by cytolytic intraepithelial lymphocytes (18) either as a target 
or as an accessory molecule. Clearly its presence on epithe- 
lium may serve as a regulator  of immune  responses. 
The nature of the immune response in the intestine is mixed. 
Whereas positive immune responses (IgA secretion) to specific 
Ags do occur (19, 20), the majority of Ags in the GI tract 
evoke either a nonresponse or quite commonly, active sup- 
pression (21).  This active suppression is dearly seen in the 
phenomenon of oral tolerance where oral immunization  to 
a protein Ag suppresses the ability of the host to become 
systemically immunized (22-24). Although the mechanism 
of induction of oral tolerance is not understood, recent studies 
have demonstrated  that  Ag presentation via IEC results in 
the activation  of CD8 + CD28-  suppressor T  cells  (5,  6). 
Furthermore,  in humans, it appears that the CD8 molecule 
itself is important  in this process as suppressor cell genera- 
tion is inhibited by anti-CD8 but not anti-CD4 mAbs (12). 
The restriction elements regulating  the activation of these 
cells  have  also been questioned as neither  mAbs to class  I 
(conventional CD8 ligand and restriction element) nor class 
II  (pretreatment  of epithelial  cells  only) Ags inhibit  IEC- 
stimulated T  cell activation in allogeneic mixed cell culture 
(12).  One plausible scenario is that  there is a novel ligand 
for CD8 that may act as a costimulatory signal for CD8 + 
T  cells.  This may exist solely as a ligand for CD8 or, like 
class I,  serving as a ligand as well as a restriction element. 
A role for CD8 in this system has been recently strengthened 
by the findings that normal epithelial cells activate the src- 
like tyrosine kinase p561ck,  associated with the ol chain of 
CD8 (25, and Li, Y., and L. Mayer, manuscript in prepara- 
tion) in peripheral blood T  cells.  Furthermore,  this activa- 
tion  appears  to be a critical event in epithelial  cell-driven 
CD8 + T  cell proliferation,  since inhibition  of tyrosine ki- 
nase by pretreatment  of responder  T  cells  with  genestein 
blocked T cell proliferation in epithelial cell-T cell allogeneic 
mixed cell cultures. 
Obvious candidates for novel CD8 ligands would be class 
I-like molecules that would serve the purposes described above. 
Clearly CDld could fall into this group despite the current 
lack of direct evidence that any of the CD1 family binds to 
CD8. Furthermore, there is no evidence that CDld can bind 
peptides allowing it  to serve as a potential  restricting  ele- 
ment for the TCR or TCR-like molecules on T  cells. 
In this study, we provide evidence for the functional im- 
portance of CDld. Besides CDS, it is the only known mole- 
cule that has been shown to be important in T cell stimula- 
tion by normal IEC. These studies strongly suggest that CDld 
is important  in CD8 ÷ T  cell activation by IEC since non 
T  cell- and AEC-stimulated allogeneic mixed cell cultures 
are not inhibited by a mAb to CDld. Both of these stimu- 
lator cells preferentially activate CD4 + T cells and the results 
from these experiments support the model that 3Cll inhibits 
cultures where CD8 ÷ T cell activation occurs. Furthermore, 
these latter experiments confirmed the fact that the anti-CDld 
mAb is not mediating nonspecific inhibition.  The findings 
in non T cell/AEC-stimulated T cell cultures were strength- 
ened by the results seen in LPL-epithelial cell cultures. Here 
again, in non-CD8 stimulatory cultures, no suppression by 
mAb 3Cll was seen. Thus CDld may be a novel CD8 ligand. 
These data suggest that it is associated with T cell activation 
and proliferation.  It remains to be determined whether this 
is  a  cognitive  or  noncognitive  event.  This  issue  can  be 
scrutinized more rigorously by the use of CDld transfectants 
where other epithelial cell surface Ags would not be avail- 
able to alter responses. 
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